Published in Gut on March 01, 1995
Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut (1996) 2.58
Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun (1996) 1.51
Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun (2007) 1.32
Association between Helicobacter pylori and gastric cancer: current knowledge and future research. World J Gastroenterol (1998) 1.22
Molecular mechanisms of H. pylori associated gastric carcinogenesis. World J Gastroenterol (1999) 1.15
Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig Dis Sci (1999) 1.12
Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut (1997) 1.07
Effect of Helicobacter pylori infection on gastric epithelial proliferation in progression from normal mucosa to gastriccarcinoma. World J Gastroenterol (1998) 1.06
Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut (1998) 1.06
Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. J Gastroenterol (2013) 1.05
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. PLoS One (2010) 1.04
Effect of Helicobacter pylori infection on gastric epithelial cell proliferation. World J Gastroenterol (2000) 1.01
Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest (1998) 0.98
Cell proliferation in gastrointestinal mucosa. J Clin Pathol (1999) 0.93
Gastric mucosal inflammation and epithelial cell turnover are associated with gastric cancer in patients with Helicobacter pylori infection. J Clin Pathol (2000) 0.92
Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection. Gut (1996) 0.86
Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture. BMC Gastroenterol (2002) 0.86
Helicobacter pylori Infection Activates the Akt-Mdm2-p53 Signaling Pathway in Gastric Epithelial Cells. Dig Dis Sci (2014) 0.86
Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol (1997) 0.85
Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma. World J Gastroenterol (2004) 0.84
Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markers. Dig Dis Sci (1998) 0.83
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut (1997) 0.82
Correlation between epithelial cell proliferation and histological grading in gastric mucosa. J Clin Pathol (1999) 0.82
Cell proliferation in type C gastritis affecting the intact stomach. J Clin Pathol (2000) 0.81
Helicobacter pylori and apoptosis. Yale J Biol Med (1999) 0.81
The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis. J Gastroenterol (2011) 0.81
Green Tea Polyphenols Reduce Gastric Epithelial Cell Proliferation and Apoptosis Stimulated by Helicobacter pylori Infection. J Clin Biochem Nutr (2007) 0.80
Sustained epithelial proliferation in a functionally irreversible fundic mucosa after Helicobacter pylori eradication. J Gastroenterol (2009) 0.80
Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis. World J Gastroenterol (2015) 0.78
Helicobacter pylori protein JHP0290 exhibits proliferative and anti-apoptotic effects in gastric epithelial cells. PLoS One (2015) 0.78
Helicobacter pylori infection and expression of DNA mismatch repair proteins. World J Gastroenterol (2008) 0.78
Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model. Am J Pathol (2009) 0.77
Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients. Dig Dis Sci (2005) 0.77
Insulin-like growth factor-I in Helicobacter pylori gastritis and response to eradication using bismuth based triple therapy. J Clin Pathol (1996) 0.77
Gastric epithelial cell proliferation in patients with liver cirrhosis. Dig Dis Sci (2001) 0.77
Cell proliferation in the post-surgical stomach, dietary salt, and the effect of H pylori eradication. J Clin Pathol (1999) 0.77
Impact of Helicobacter pylori on the healing process of the gastric barrier. World J Gastroenterol (2016) 0.76
The Helicobacter pylori fatty acid cis-9,10-methyleneoctadecanoic acid stimulates protein kinase C and increases DNA synthesis of gastric HM02 cells. Br J Cancer (1998) 0.76
Gastric and duodenal mucosal protein fractional synthesis and growth factor expression in patients with H. pylori-associated gastritis before and after eradication of the organism. Dig Dis Sci (2004) 0.75
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ (1991) 9.88
Too many rodent carcinogens: mitogenesis increases mutagenesis. Science (1990) 8.39
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Ascorbate-nitrite reaction: possible means of blocking the formation of carcinogenic N-nitroso compounds. Science (1972) 2.54
Intestinal metaplasia of the gastric mucosa. Br J Cancer (1955) 2.41
Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol (1991) 2.16
Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J Pathol (1992) 1.63
Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58
Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. J Pathol (1992) 1.55
Ascorbic acid: a factor concentrated in human gastric juice. Clin Sci (Lond) (1989) 1.36
Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut (1993) 1.32
Free radicals: their involvement in disease processes. Ann Clin Biochem (1990) 1.22
Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol (1994) 1.09
A rapid, accurate, immunohistochemical method to label proliferating cells in the digestive tract. A comparison with tritiated thymidine. Gastroenterology (1991) 1.01
The use of bismuth in gastroenterology. The ACG Committee on FDA-Related Matters. American College of Gastroenterology. Am J Gastroenterol (1991) 0.99
Growth regulatory peptides in gastric mucosa. Clin Sci (Lond) (1992) 0.97
Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application. Cancer (1992) 0.93
The immune response. 2. Systemic mediators of inflammation. Br J Hosp Med (1991) 0.92
Cell proliferation in normal and diseased gastric mucosa. Autoradiography after in vitro continuous labelling with tritiated thymidine. Acta Pathol Microbiol Scand A (1979) 0.87
The inhibition of bacterially mediated N-nitrosation by vitamin C: relevance to the inhibition of endogenous N-nitrosation in the achlorhydric stomach. Carcinogenesis (1989) 0.86
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA (2001) 7.48
Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J Bacteriol (1997) 6.93
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut (2008) 5.86
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ (1997) 5.80
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Early endoscopy of oesophagus, stomach, and duodenal bulb in patients with haematemesis and melaena. Br Med J (1973) 4.84
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet (2001) 3.76
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg (2010) 3.63
Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol (1990) 3.30
Transcatheter occlusion of foramen ovale with a button device after neurological decompression illness in professional divers. Lancet (1996) 3.27
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet (1999) 3.15
The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell (1989) 3.07
Cost effectiveness of antenatal screening for cystic fibrosis. BMJ (1995) 3.05
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg (2010) 3.03
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg (2012) 2.93
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Unlocking the archive--gene expression in paraffin-embedded tissue. J Pathol (2001) 2.76
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
Placental malaria. I. Pathological classification. Histopathology (1993) 2.62
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem (1983) 2.57
Sequence, assembly and analysis of pX01 and pX02. J Appl Microbiol (1999) 2.53
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 2.41
Pancreatography in chronic pancreatitis: international definitions. Gut (1984) 2.37
Early gastric cancer in Europe. Gut (1997) 2.34
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26
Identification of Sarcocystis capracanis in cerebrospinal fluid from sheep with neurological disease. Vet Parasitol (2012) 2.23
Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg (2010) 2.23
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Effect of cimetidine on the gastric bacterial flora. Lancet (1980) 2.18
Fractures involving splitting of the humeral head. J Bone Joint Surg Br (2001) 2.18
Follicular stimulation for high tech pregnancies: are we playing it safe? BMJ (1989) 2.18
The sequence and topology of human complement component C9. EMBO J (1985) 2.18
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J (1978) 2.12
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
C1 inhibitor deficiency: consensus document. Clin Exp Immunol (2005) 2.07
Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. BMJ (1989) 2.07
Factors influencing the psychological impact of prolonged unemployment and of re-employment. Psychol Med (1985) 2.03
Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology (2007) 2.01
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology (1985) 1.97
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Sensitivity of the retina to radiation damage as a function of wavelength. Photochem Photobiol (1979) 1.90
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J Clin Invest (1998) 1.87
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut (1986) 1.83